Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of R-CEEP (Rituximab, Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) in Elderly or Unfit Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Retrospective Single-Centre Experience

James Yeung, MBBS, Ashlea Campbell, BSc MBBS FRACP FRCPA, Christian E Bryant, MBBS PhDFRACP FRCPA, Liane Khoo, MBBS PhDFRACP FRCPA, Scott Dunkley, MBBS FRACP FRCPA, Harry J Iland, MBBS FRACP FRCPA MHGSA, Stephen R Larsen, MBBS PhDFRACP FRCPA, Susan Moreton, MBBS FRACP FRCPA, Douglas E Joshua, BSc(Hons) MBBS DPhil FRACP FRCPA, Vinay Vanguru, MBBS FRACP FRCPA, Derek A McCulloch, BSc MBBChir PhDFRACP FRCPA, Danny Hsu, MBBS FRACP FRCPA, John Gibson, MBBS PhDFRACP FRCPA, P. Joy Ho, MBBS DPhil FRACP FRCPA, Christina Brown, MBBS PhDFRACP FRCPA

Blood (2019) 134 (Supplement_1): 2911.

https://doi.org/10.1182/blood-2019-131589

Published: 2019

Journal Articles

Bing Neel Syndrome: Retrospective Australasian Experience of a Rare Treatable Complication of Waldenström Macroglobulinaemia/ Lymphoplasmacytic Lymphoma

Dipti Talaulikar, PhD FRACP, FRCPA, MBBS, Tara Cochrane, MBBS, John Gibson, Nada Hamad, MBBS, BSc, MSc, Phoebe Joy Ho, MBBS DPhil FRACP FRCPA, Samar Issa, FRACP, Kwok Fiona, Jun Hee Lim, PhD, David Simpson, MBChB, FRACP, FRCPA, Constantine Tam, MD PhD, Jorge J. Castillo, MD

Blood (2018) 132 (Supplement 1): 5325.

https://doi.org/10.1182/blood-2018-99-113969

Published: 2018

Journal Articles

A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia Expands Anti-Tumour T Cell Responses at Remission

Derek NJ Hart, PhD FRCPA, FRACP, MB, Jennifer L Hsu, Christian E Bryant, Michael S Papadimitrious, Benjamin Kong, Robin E Gasiorowski, Daniel W Orellana, Helen McGuire, Barbara Fazekas de St Groth, Douglas E. Joshua, Phoebe Joy Ho, Stephen R Larsen, Harry J Iland, John Gibson, Georgina J Clark, Phillip D Fromm

Blood (2017) 130 (Supplement 1): 2648.

https://doi.org/10.1182/blood.V130.Suppl_1.2648.2648

Published: 2017

Journal Articles

Red Cell Transport Abnormalities As Predictors of the Development of Renal Disease in Children with Sickle Cell Disease

Sanjay Tewari, MBBS, MRCPCH, John Gibson, Stephan Menzel, PhD, Anke Hannemann, Swee Lay Thein, MD, Bukola T Gbotosho, Halima W M Al Balushi, David C Rees, MA, FRCP

Blood (2016) 128 (22): 1317.

https://doi.org/10.1182/blood.V128.22.1317.1317

Published: 2016

Journal Articles

A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia

Jennifer Hsu, PhD, Christian Bryant, Phillip Fromm, PhD, Michael Papadimitrious, Daniel Orellana, Hayley Suen, Shihong Yang, Claire Weatherburn, Robin Gasiorowski, Harry J Iland, MBBS FRACP FRCPA, Ross D Brown, Douglas E Joshua, Phoebe Joy Ho, MBBS, DPhil, John Gibson, Georgina Clark, Derek NJ Hart

Blood (2016) 128 (22): 5221.

https://doi.org/10.1182/blood.V128.22.5221.5221

Published: 2016

Journal Articles

CD16+ Dendritic Cells Are a Unique Myeloid Antigen Presenting Cell Population

Phillip Fromm, PhD, Michael Papadimitrious, Jennifer Hsu, PhD, Stephen Robert Larsen, MBBS PhD FRCPA FRACP, John Gibson, Kenneth Bradstock, MBBS, PhD, Fiona Kupresanin, Georgina Clark, Derek NJ Hart

Blood (2016) 128 (22): 4897.

https://doi.org/10.1182/blood.V128.22.4897.4897

Published: 2016

Journal Articles

Phospho-Flow Cytometry Quantitation of STAT Signalling Checkpoints in Malignant and Non-Malignant Cells Identifies Patients Suitable for pSTAT3 and 5 Targeted Inhibitors

Ross D Brown, P Joy Ho, Douglas E Joshua, Shihong Yang, Christian Bryant, Hayley Suen, Claire Weatherburn, Stephen Larsen, Derek NJ Hart, John Gibson

Blood (2015) 126 (23): 5356.

https://doi.org/10.1182/blood.V126.23.5356.5356

Published: 2015

Journal Articles

Protective Cytotoxic Clonal T-Cells in Myeloma Have the Characteristics of Telomere-Independent Senescence Rather Than an Exhausted or Anergic Phenotype: Implications for Immunotherapy

Hayley Suen, BSc (Hons), Douglas E Joshua, MBBS DPhil, Ross D Brown, PhD, Shihong Yang, MSc, Pasquale Mario Barbaro, MBBS, P Joy Ho, MBBS DPhil, John Gibson, MBBS PhD

Blood (2014) 124 (21): 3367.

https://doi.org/10.1182/blood.V124.21.3367.3367

Published: 2014

Journal Articles

Ten Year Survival in Patients with Myeloma Is Characterized by the Persistence of Immunological Control Which Is Detected by Immunological Biomarkers

Ross D Brown, PhD, Hayley Suen, BSc (Hons), Christian E Bryant, MBBS, Shihong Yang, MSc, James Favaloro, BSc, John Gibson, MBBS PhD, P Joy Ho, MBBS, DPhil, Phillip Fromm, PhD, Derek NJ Hart, MBCHB, DPhil, Douglas E Joshua, MBBS, DPhil

Blood (2012) 120 (21): 1818.

https://doi.org/10.1182/blood.V120.21.1818.1818

Published: 2012

Journal Articles

Blockade of the Hedgehog Signaling Pathway by the Novel Agent NVP-LDE225 Induces Differentiation, Prevents De-Differentiation and Inhibits Proliferation of Multiple Myeloma Stem Cells in Vitro

Shihong Yang, MSc, Ross D Brown, PhD, Yen S Loh, PhD, Hayley Suen, BSc (Hons), James Favaloro, BSc, John Gibson, MBBS, PhD, Phoebe Joy Ho, MBBS, DPhil, Douglas E Joshua, MBBS, DPhil

Blood (2012) 120 (21): 3950.

https://doi.org/10.1182/blood.V120.21.3950.3950

Published: 2012

Journal Articles

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

Blood (2012) 120 (20): 4256–4262.

https://doi.org/10.1182/blood-2012-06-436725

Published: 2012

Includes: Supplemental data

Journal Articles

CD86 + or HLA-G + can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis

Ross Brown, Karieshma Kabani, James Favaloro, Shihong Yang, P. Joy Ho, John Gibson, Phillip Fromm, Hayley Suen, Narelle Woodland, Najah Nassif, Derek Hart, Douglas Joshua

Blood (2012) 120 (10): 2055–2063.

https://doi.org/10.1182/blood-2012-03-416792

Published: 2012

Journal Articles

Safety and Efficacy of CEEP (Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) with or without Rituximab in Elderly Patients (>70) with Diffuse Large B-Cell Lymphoma (DLBL): A Retrospective Single Center Experience

Danny Hsu, MBBS FRACP FRCPA, Ibrahim Tohidi-Esfahani, MBBS, Christina Brown, MBBS PhD FRACP FRCPA, Scott Dunkley, MBBS FRACP FRCPA, Stephen Robert Larsen, MBBS FRACP FRCPA PhD, Phoebe Joy Ho, MBBS FRCPA FRACP DPhil, Harry Iland, MBBS FRACP FRCPA MHGSA, John Gibson, MBBS FRACP FRCPA DPhil, Douglas E. Joshua, MBBS DPhil FRACP FRCPA AM

Blood (2011) 118 (21): 4957.

https://doi.org/10.1182/blood.V118.21.4957.4957

Published: 2011

Journal Articles

Ten Year Survivors of Multiple Myeloma Demonstrate a Differential Expression of Immunological Biomarkers Including a High Incidence of Cytotoxic T-Cell Clones Which Have Not Acquired Myeloma-Associated Anergy,

Christian E Bryant, MBBS, Ross D Brown, DPhil, Shihong Yang, BSc, Hayley Suen, BSc, Esther Aklilu, BSc, James Favaloro, BSc, Derek NJ Hart, MBCHB, DPhil, Phillip Fromm, DPhil, Narelle Woodland, MSc, Najah Nassif, DPhil, Harry Iland, MBBS FRACP FRCPA MHGSA, John Gibson, MBBS FRACP FRCPA DPhil, P Joy Ho, MBBS, DPhil, Douglas E Joshua, MBBS, DPhil

Blood (2011) 118 (21): 3924.

https://doi.org/10.1182/blood.V118.21.3924.3924

Published: 2011

Journal Articles

HLA-G and CD86 Expression on Malignant Plasma Cells Convey a Poor Prognosis and Immunoregulate T Cells In Patients with Myeloma

Ross D. Brown, PhD, Karieshma Kabani, Shihong Yang, Esther Aklilu, Phoebe Joy Ho, MBBS, John Gibson, MBBS, Douglas E. Joshua, MBBS, DPhil

Blood (2010) 116 (21): 983.

https://doi.org/10.1182/blood.V116.21.983.983

Published: 2010

Journal Articles

Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells

Santi Suryani, David A. Fulcher, Brigitte Santner-Nanan, Ralph Nanan, Melanie Wong, Peter J. Shaw, John Gibson, Andrew Williams, Stuart G. Tangye

Blood (2010) 115 (3): 519–529.

https://doi.org/10.1182/blood-2009-07-234799

Published: 2010

Includes: Supplemental data

Journal Articles

Trogocytosis in Multiple Myeloma.

Ross D. Brown, PhD, MBA, Karieshma Kabani, BSc, Shihong Yang, MSc, Aklilu Esther, BSc, Phoebe Joy Ho, MBBS, DPhil, John Gibson, MBBS, PhD, Douglas E. Joshua, MBBS, DPhil

Blood (2008) 112 (11): 1681.

https://doi.org/10.1182/blood.V112.11.1681.1681

Published: 2008

Journal Articles

Donor Characteristics Affecting Graft Failure and Survival after Unrelated Donor Transplantation with Reduced Intensity Conditioning Regimens (RIC) for Hematologic Malignancies.

Jakob R. Passweg, MD, MS, Fangyu Kan, MS, MA, Mei-Jie Zhang, PhD, Vanderson Rocha, MD, PhD, Luis M. Isola, MD, Adrian P. Gee, PhD, John Gibson, MBBS, FRACP, FRCPA, Hillard M. Lazarus, MD, Mary J. Laughlin, MD, Alison Loren, MD, MS, David Marks, MD, PhD, Alois Gratwohl, Mary Eapen, MBBS

Blood (2008) 112 (11): 1968.

https://doi.org/10.1182/blood.V112.11.1968.1968

Published: 2008

Journal Articles

Optimizing Mobilization, Augmentation, and Gene Transfer of Multipotent Mesenchymal Stromal Cells (MSCs).

Stephen R. Larsen, MBBS, Keefe Chng, BVSc, Shangzhen Zhou, John Wright, PhD, Margaret Armstrong, Sally Thompson, BVSc, Annemarie Hennessy, MBBS PhD, Rosetta Martiniello-Wilks, BSc PhD, John Gibson, MBBS PhD, Douglas E. Joshua, MBBS PhD, John E.J. Rasko, MBBS PhD

Blood (2006) 108 (11): 2555.

https://doi.org/10.1182/blood.V108.11.2555.2555

Published: 2006

Journal Articles

Differentiation of Multiple Myeloma and MGUS by Cross Validated Differential Proteomic Analysis.

Ross D. Brown, PhD, Larissa Belov, PhD, Cris dos Remedios, PhD, Daniel Sze, PhD, Simon Cooper, Mila Dolotin, John Gibson, MD, Douglas E. Joshua, MD

Blood (2006) 108 (11): 3524.

https://doi.org/10.1182/blood.V108.11.3524.3524

Published: 2006

NARROW

Safety and Efficacy of R-CEEP (Rituximab, Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) in Elderly or Unfit Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Retrospective Single-Centre Experience

Bing Neel Syndrome: Retrospective Australasian Experience of a Rare Treatable Complication of Waldenström Macroglobulinaemia/ Lymphoplasmacytic Lymphoma

A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia Expands Anti-Tumour T Cell Responses at Remission

Red Cell Transport Abnormalities As Predictors of the Development of Renal Disease in Children with Sickle Cell Disease

A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia

CD16+ Dendritic Cells Are a Unique Myeloid Antigen Presenting Cell Population

Phospho-Flow Cytometry Quantitation of STAT Signalling Checkpoints in Malignant and Non-Malignant Cells Identifies Patients Suitable for pSTAT3 and 5 Targeted Inhibitors

Protective Cytotoxic Clonal T-Cells in Myeloma Have the Characteristics of Telomere-Independent Senescence Rather Than an Exhausted or Anergic Phenotype: Implications for Immunotherapy

Ten Year Survival in Patients with Myeloma Is Characterized by the Persistence of Immunological Control Which Is Detected by Immunological Biomarkers

Blockade of the Hedgehog Signaling Pathway by the Novel Agent NVP-LDE225 Induces Differentiation, Prevents De-Differentiation and Inhibits Proliferation of Multiple Myeloma Stem Cells in Vitro

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

CD86 + or HLA-G + can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis

Safety and Efficacy of CEEP (Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) with or without Rituximab in Elderly Patients (>70) with Diffuse Large B-Cell Lymphoma (DLBL): A Retrospective Single Center Experience

Ten Year Survivors of Multiple Myeloma Demonstrate a Differential Expression of Immunological Biomarkers Including a High Incidence of Cytotoxic T-Cell Clones Which Have Not Acquired Myeloma-Associated Anergy,

HLA-G and CD86 Expression on Malignant Plasma Cells Convey a Poor Prognosis and Immunoregulate T Cells In Patients with Myeloma

Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells

Trogocytosis in Multiple Myeloma.

Donor Characteristics Affecting Graft Failure and Survival after Unrelated Donor Transplantation with Reduced Intensity Conditioning Regimens (RIC) for Hematologic Malignancies.

Optimizing Mobilization, Augmentation, and Gene Transfer of Multipotent Mesenchymal Stromal Cells (MSCs).

Differentiation of Multiple Myeloma and MGUS by Cross Validated Differential Proteomic Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only